{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:46:21Z","timestamp":1793040381604,"version":"4.5.0"},"reference-count":199,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III, Health Research Fund","doi-asserted-by":"publisher","award":["CIBEROBNCB12\/03\/30038"],"award-info":[{"award-number":["CIBEROBNCB12\/03\/30038"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CN"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Attention-Deficit Hyperactivity Disorder (ADHD) is a highly prevalent childhood psychiatric\ndisorder. In general, a child with ADHD has significant attention problems with difficulty\nconcentrating on a subject and is generally associated with impulsivity and excessive activity. The\netiology of ADHD in most patients is unknown, although it is considered to be a multifactorial disease\ncaused by a combination of genetics and environmental factors. Diverse factors, such as the existence\nof mental, nutritional, or general health problems during childhood, as well as smoking and\nalcohol drinking during pregnancy, are related to an increased risk of ADHD. Behavioral and psychological\ncharacteristics of ADHD include anxiety, mood disorders, behavioral disorders, language\ndisorders, and learning disabilities. These symptoms affect individuals, families, and communities,\nnegatively altering educational and social results, strained parent-child relationships, and increased\nuse of health services. ADHD may be associated with deficits in inhibitory frontostriatal noradrenergic\nneurons on lower striatal structures that are predominantly driven by dopaminergic neurons.\nPhosphoinositide 3-kinases (PI3Ks) are a conserved family of lipid kinases that control a number of\ncellular processes, including cell proliferation, differentiation, migration, insulin metabolism, and\napoptosis. Since PI3K plays an important role in controlling the noradrenergic neuron, it opens up\nnew insights into research on ADHD and other developmental brain diseases. This review presents\nevidence for the potential usefulness of PI3K and its modulators as a potential treatment for ADHD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1570159x20666220119125040","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T07:02:53Z","timestamp":1642575773000},"page":"1564-1578","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting PI3K by Natural Products: A Potential Therapeutic Strategy for\nAttention-deficit Hyperactivity Disorder"],"prefix":"10.2174","volume":"20","author":[{"given":"Tayebeh","family":"Noori","sequence":"first","affiliation":[{"name":"Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mousa","family":"Sahebgharani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Sureda","sequence":"additional","affiliation":[{"name":"Research Group on Community Nutrition and Oxidative Stress (NUCOX) and Health Research Institute of Balearic\nIslands (IdISBa), University of Balearic Islands-IUNICS, Palma de Mallorca E-07122, Balearic Islands, Spain"},{"name":"CIBER\nFisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n (CIBEROBN), Instituto de Salud Carlos III (ISCIII), 28029 Madrid, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sobarzo-Sanchez","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n y Postgrado, Facultad de Ciencias de la Salud, Universidad Central de Chile, Chile"},{"name":"Department of Organic Chemistry, Faculty of Pharmacy, University of Santiago de Compostela, Santiago, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajad","family":"Fakhri","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Shirooie","sequence":"additional","affiliation":[{"name":"Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah,\nIran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00787-017-1008-9","volume":"27","author":"Evans S.","year":"2018","unstructured":"Evans S.; Ling M.; Hill B.; Rinehart N.; Austin D.; Sciberras E.; Systematic review of meditation-based interventions for children with ADHD. Eur Child Adolesc Psychiatry 2018,27(1),9-27","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fnhum.2019.00042","volume":"13","author":"Luo Y.","year":"2019","unstructured":"Luo Y.; Weibman D.; Halperin J.M.; Li X.; A review of heterogeneity in attention deficit\/hyperactivity disorder (ADHD). Front Hum Neurosci 2019,13,42","journal-title":"Front Hum Neurosci"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/1471-244X-13-298","volume":"13","author":"Skogli E.W.","year":"2013","unstructured":"Skogli E.W.; Teicher M.H.; Andersen P.N.; Hovik K.T.; &#xD8;ie M.; ADHD in girls and boys--gender differences in co-existing symptoms and executive function measures. BMC Psychiatry 2013,13(1),298","journal-title":"BMC Psychiatry"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/jpm11030166","volume":"11","author":"N&#xFA;&#xF1;ez-Jaramillo L.","year":"2021","unstructured":"N&#xFA;&#xF1;ez-Jaramillo L.; Herrera-Sol&#xED;s A.; Herrera-Morales W.V.; ADHD: Reviewing the causes and evaluating solutions. J Pers Med 2021,11(3),166","journal-title":"J Pers Med"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00787-017-1005-z","volume":"26","author":"Reale L.","year":"2017","unstructured":"Reale L.; Bartoli B.; Cartabia M.; Zanetti M.; Costantino M.A.; Canevini M.P.; Termine C.; Bonati M.; Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry 2017,26(12),1443-1457","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tics.2006.01.011","volume":"10","author":"Castellanos F.X.","year":"2006","unstructured":"Castellanos F.X.; Sonuga-Barke E.J.; Milham M.P.; Tannock R.; Characterizing cognition in ADHD: Beyond executive dysfunction. Trends Cogn Sci 2006,10(3),117-123","journal-title":"Trends Cogn Sci"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.dcn.2014.12.005","volume":"11","author":"Costa Dias T.G.","year":"2015","unstructured":"Costa Dias T.G.; Iyer S.P.; Carpenter S.D.; Cary R.P.; Wilson V.B.; Mitchell S.H.; Nigg J.T.; Fair D.A.; Characterizing heterogeneity in children with and without ADHD based on reward system connectivity. Dev Cogn Neurosci 2015,11,155-174","journal-title":"Dev Cogn Neurosci"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1016\/S0140-6736(14)61822-5","volume":"385","author":"Faraone S.V.","year":"2015","unstructured":"Faraone S.V.; Attention deficit hyperactivity disorder and premature death. Lancet 2015,385(9983),2132-2133","journal-title":"Lancet"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.24869\/psyd.2020.168","volume":"32","year":"2020","unstructured":"&#xD6;&#x11F;&#xFC;tl&#xFC;, H.; Esin, \u0130.S.; Erdem, H.B.; Tatar, A.; Dursun, O.B. Mitochondrial DNA copy number is associated with attention deficit hyperac-tivity disorder. Psychiatr Danub 2020,32(2),168-175","journal-title":"Psychiatr Danub"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S0166-4328(01)00425-9","volume":"130","author":"Russell V.A.","year":"2002","unstructured":"Russell V.A.; Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hy-peractivity disorder--the spontaneously hypertensive rat. Behav Brain Res 2002,130(1-2),191-196","journal-title":"Behav Brain Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1017\/S0140525X05000075","volume":"28","author":"Sagvolden T.","year":"2005","unstructured":"Sagvolden T.; Johansen E.B.; Aase H.; Russell V.A.; A dynamic developmental theory of attention-deficit\/hyperactivity disorder (ADHD) predominantly hyperactive\/impulsive and combined subtypes. Behav Brain Sci 2005,28(3),397-419","journal-title":"Behav Brain Sci"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1056\/NEJMcp1307215","volume":"370","author":"Feldman H.M.","year":"2014","unstructured":"Feldman H.M.; Reiff M.I.; Clinical practice. Attention deficit-hyperactivity disorder in children and adolescents. N Engl J Med 2014,370(9),838-846","journal-title":"N Engl J Med"},{"key":"ref=13","year":"2013","unstructured":"American Psychiatric Association. A; Association, A P, Diagnostic\nand statistical manual of mental disorders: DSM-5; American psychiatric association: Washington, DC2013","journal-title":"A; Association, A P, Diagnostic\nand statistical manual of mental disorders: DSM-5;"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1177\/1087054718821734","volume":"25","author":"Taylor L.E.","year":"2021","unstructured":"Taylor L.E.; Antshel K.M.; Factors associated with parental treatment attitudes and information-seeking behaviors for childhood ADHD. J Atten Disord 2021,25(4),607-617","journal-title":"J Atten Disord"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1017\/S0033291720000069","volume":"50","author":"Nimmo-Smith V.","year":"2020","unstructured":"Nimmo-Smith V.; Merwood A.; Hank D.; Brandling J.; Greenwood R.; Skinner L.; Law S.; Patel V.; Rai D.; Non-pharmacological interventions for adult ADHD: A systematic review. Psychol Med 2020,50(4),529-541","journal-title":"Psychol Med"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.3390\/ijms19123725","volume":"19","author":"S&#xE1;nchez-Alegr&#xED;a K.","year":"2018","unstructured":"S&#xE1;nchez-Alegr&#xED;a K.; Flores-Le&#xF3;n M.; Avila-Mu&#xF1;oz E.; Rodr&#xED;guez-Corona N.; Arias C.; PI3K signaling in neurons: A central node for the control of multiple functions. Int J Mol Sci 2018,19(12),3725","journal-title":"Int J Mol Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"e274","DOI":"10.1371\/journal.pbio.0050274","volume":"5","author":"Williams J.M.","year":"2007","unstructured":"Williams J.M.; Owens W.A.; Turner G.H.; Saunders C.; Dipace C.; Blakely R.D.; France C.P.; Gore J.C.; Daws L.C.; Avison M.J.; Galli A.; Hypoinsulinemia regulates amphetamine-induced reverse transport of dopamine. PLoS Biol 2007,5(10),e274","journal-title":"PLoS Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.15252\/emmm.201505266","volume":"7","author":"Darcq E.","year":"2015","unstructured":"Darcq E.; Kieffer B.L.; PI3K signaling in the locus coeruleus: A new molecular pathway for ADHD research. EMBO Mol Med 2015,7(7),859-861","journal-title":"EMBO Mol Med"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/S0006-3223(99)00140-7","volume":"46","author":"Aston-Jones G.","year":"1999","unstructured":"Aston-Jones G.; Rajkowski J.; Cohen J.; Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 1999,46(9),1309-1320","journal-title":"Biol Psychiatry"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"Cantley L.C.","year":"2002","unstructured":"Cantley L.C.; The phosphoinositide 3-kinase pathway. Science 2002,296(5573),1655-1657","journal-title":"Science"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1038\/nn.2937","volume":"14","author":"Kim J-I.","year":"2011","unstructured":"Kim J-I.; Lee H-R.; Sim S.E.; Baek J.; Yu N-K.; Choi J-H.; Ko H-G.; Lee Y-S.; Park S-W.; Kwak C.; Ahn S.J.; Choi S.Y.; Kim H.; Kim K.H.; Backx P.H.; Bradley C.A.; Kim E.; Jang D.J.; Lee K.; Kim S.J.; Zhuo M.; Collingridge G.L.; Kaang B.K.; PI3K&#x3B3; is required for NMDA receptor-dependent long-term depression and behavioral flexibility. Nat Neurosci 2011,14(11),1447-1454","journal-title":"Nat Neurosci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"904","DOI":"10.15252\/emmm.201404697","volume":"7","author":"D\u2019Andrea I.","year":"2015","unstructured":"D\u2019Andrea I.; Fardella V.; Fardella S.; Pallante F.; Ghigo A.; Iacobucci R.; Maffei A.; Hirsch E.; Lembo G.; Carnevale D.; Lack of kinase-independent activity of PI3K&#x3B3; in locus coeruleus induces ADHD symptoms through increased CREB signaling. EMBO Mol Med 2015,7(7),904-917","journal-title":"EMBO Mol Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"107782","DOI":"10.1016\/j.neuropharm.2019.107782","volume":"166","author":"Alves C.B.","year":"2020","unstructured":"Alves C.B.; Almeida A.S.; Marques D.M.; Fa&#xE9; A.H.L.; Machado A.C.L.; Oliveira D.L.; Portela L.V.C.; Porci&#xFA;ncula L.O.; Caffeine and adenosine A2A receptors rescue neuronal development in vitro of frontal cortical neurons in a rat model of attention deficit and hyperactiv-ity disorder. Neuropharmacology 2020,166,107782","journal-title":"Neuropharmacology"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/cch.12139","volume":"40","author":"Tarver J.","year":"2014","unstructured":"Tarver J.; Daley D.; Sayal K.; Attention-deficit hyperactivity disorder (ADHD): An updated review of the essential facts. Child Care Health Dev 2014,40(6),762-774","journal-title":"Child Care Health Dev"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","volume":"57","author":"Faraone S.V.","year":"2005","unstructured":"Faraone S.V.; Perlis R.H.; Doyle A.E.; Smoller J.W.; Goralnick J.J.; Holmgren M.A.; Sklar P.; Molecular genetics of attention-deficit\/hyperactivity disorder. Biol Psychiatry 2005,57(11),1313-1323","journal-title":"Biol Psychiatry"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.psc.2009.12.004","volume":"33","author":"Faraone S.V.","year":"2010","unstructured":"Faraone S.V.; Mick E.; Molecular genetics of attention deficit hyperactivity disorder. Psychiatr Clin North Am 2010,33(1),159-180","journal-title":"Psychiatr Clin North Am"},{"key":"ref=27","first-page":"S81","volume":"54","author":"Fern&#xE1;ndez-Ja&#xE9;n A.","year":"2012","unstructured":"Fern&#xE1;ndez-Ja&#xE9;n A.; Fern&#xE1;ndez-Mayoralas D.M.; Calleja-P&#xE9;rez B.; Mu&#xF1;oz-Jare&#xF1;o N.; L&#xF3;pez-Arribas S.; Genomic endophenotypes of attention deficit hyperactivity disorder. Rev Neurol 2012,54(Suppl. 1),S81-S87","journal-title":"Rev Neurol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00439-009-0694-x","volume":"126","author":"Gizer I.R.","year":"2009","unstructured":"Gizer I.R.; Ficks C.; Waldman I.D.; Candidate gene studies of ADHD: A meta-analytic review. Hum Genet 2009,126(1),51-90","journal-title":"Hum Genet"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/00041444-200503000-00009","volume":"15","author":"Purper-Ouakil D.","year":"2005","unstructured":"Purper-Ouakil D.; Wohl M.; Mouren M.C.; Verpillat P.; Ad&#xE8;s J.; Gorwood P.; Meta-analysis of family-based association studies be-tween the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 2005,15(1),53-59","journal-title":"Psychiatr Genet"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/1096-8628(20010108)105:1<91:AID-AJMG1069>3.0.CO;2-V","volume":"105","author":"Manor I.","year":"2001","unstructured":"Manor I.; Eisenberg J.; Tyano S.; Sever Y.; Cohen H.; Ebstein R.P.; Kotler M.; Family-based association study of the serotonin trans-porter promoter region polymorphism (5-HTTLPR) in attention deficit hyperactivity disorder. Am J Med Genet 2001,105(1),91-95","journal-title":"Am J Med Genet"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000360367","volume":"69","author":"Grant P.","year":"2014","unstructured":"Grant P.; Kuepper Y.; Wielpuetz C.; Hennig J.; Differential associations of dopamine-related polymorphisms with discrete components of reaction time variability: Relevance for attention deficit\/hyperactivity disorder. Neuropsychobiology 2014,69(4),220-226","journal-title":"Neuropsychobiology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.3390\/ijms16023095","volume":"16","author":"Kitagishi Y.","year":"2015","unstructured":"Kitagishi Y.; Minami A.; Nakanishi A.; Ogura Y.; Matsuda S.; Neuron membrane trafficking and protein kinases involved in autism and ADHD. Int J Mol Sci 2015,16(2),3095-3115","journal-title":"Int J Mol Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/nu13010249","volume":"13","author":"Checa-Ros A.","year":"2021","unstructured":"Checa-Ros A.; Jer&#xE9;z-Calero A.; Molina-Carballo A.; Campoy C.; Mu&#xF1;oz-Hoyos A.; Current evidence on the role of the gut microbiome in ADHD pathophysiology and therapeutic implications. Nutrients 2021,13(1),249","journal-title":"Nutrients"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1053\/j.gastro.2011.04.052","volume":"141","author":"Bercik P.","year":"2011","unstructured":"Bercik P.; Denou E.; Collins J.; Jackson W.; Lu J.; Jury J.; Deng Y.; Blennerhassett P.; Macri J.; McCoy K.D.; The intestinal\nmicrobiota affect central levels of brain-derived neurotropic factor\nand behavior in mice. Gastroenterology e13.2011,141(2),599-609","journal-title":"Gastroenterology"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.gtc.2019.05.001","volume":"48","author":"Dam S.A.","year":"2019","unstructured":"Dam S.A.; Mostert J.C.; Szopinska-Tokov J.W.; Bloemendaal M.; Amato M.; Arias-Vasquez A.; The role of the gut-brain axis in atten-tion-deficit\/hyperactivity disorder. Gastroenterology Clinics 2019,48(3),407-431","journal-title":"Gastroenterology Clinics"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/jnr.23275","volume":"92","author":"Kim P.","year":"2014","unstructured":"Kim P.; Choi C.S.; Park J.H.; Joo S.H.; Kim S.Y.; Ko H.M.; Kim K.C.; Jeon S.J.; Park S.H.; Han S.H.; Ryu J.H.; Cheong J.H.; Han J.Y.; Ko K.N.; Shin C.Y.; Chronic exposure to ethanol of male mice before mating produces attention deficit hyperactivity disorder-like phenotype along with epigenetic dysregulation of dopamine transporter expression in mouse offspring. J Neurosci Res 2014,92(5),658-670","journal-title":"J Neurosci Res"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41398-020-00999-9","volume":"10","author":"Yde Ohki C.M.","year":"2020","unstructured":"Yde Ohki C.M.; Grossmann L.; Alber E.; Dwivedi T.; Berger G.; Werling A.M.; Walitza S.; Gr&#xFC;nblatt E.; The stress-Wnt-signaling axis: A hypothesis for attention-deficit hyperactivity disorder and therapy approaches. Transl Psychiatry 2020,10(1),315","journal-title":"Transl Psychiatry"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ajmg.b.32346","volume":"171","author":"Aebi M.","year":"2016","unstructured":"Aebi M.; van Donkelaar M.M.; Poelmans G.; Buitelaar J.K.; Sonuga-Barke E.J.; Stringaris A.; Consortium I.; Faraone S.V.; Franke B.; Steinhausen H.C.; van Hulzen K.J.; Gene-set and multivariate genome-wide association analysis of oppositional defiant behavior sub-types in attention-deficit\/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 2016,171(5),573-588","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1176\/appi.ajp.2011.11040551","volume":"169","author":"Stergiakouli E.","year":"2012","unstructured":"Stergiakouli E.; Hamshere M.; Holmans P.; Langley K.; Zaharieva I.; Hawi Z.; Kent L.; Gill M.; Williams N.; Owen M.J.; O\u2019Donovan M.; Thapar A.; Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry 2012,169(2),186-194","journal-title":"Am J Psychiatry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1176\/appi.ajp.2011.11060822","volume":"169","author":"Williams N.M.","year":"2012","unstructured":"Williams N.M.; Franke B.; Mick E.; Anney R.J.; Freitag C.M.; Gill M.; Thapar A.; O\u2019Donovan M.C.; Owen M.J.; Holmans P.; Kent L.; Middleton F.; Zhang-James Y.; Liu L.; Meyer J.; Nguyen T.T.; Romanos J.; Romanos M.; Seitz C.; Renner T.J.; Walitza S.; Warnke A.; Palmason H.; Buitelaar J.; Rommelse N.; Vasquez A.A.; Hawi Z.; Langley K.; Sergeant J.; Steinhausen H.C.; Roeyers H.; Biederman J.; Zaharieva I.; Hakonarson H.; Elia J.; Lionel A.C.; Crosbie J.; Marshall C.R.; Schachar R.; Scherer S.W.; Todorov A.; Smalley S.L.; Loo S.; Nelson S.; Shtir C.; Asherson P.; Reif A.; Lesch K.P.; Faraone S.V.; Genome-wide analysis of copy number var-iants in attention deficit hyperactivity disorder: The role of rare variants and duplications at 15q13.3. Am J Psychiatry 2012,169(2),195-204","journal-title":"Am J Psychiatry"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1176\/appi.ajp.2018.18040383","volume":"175","author":"Thapar A.","year":"2018","unstructured":"Thapar A.; Discoveries on the genetics of ADHD in the 21st century: New findings and their implications. Am J Psychiatry 2018,175(10),943-950","journal-title":"Am J Psychiatry"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41588-018-0269-7","volume":"51","author":"Demontis D.","year":"2019","unstructured":"Demontis D.; Walters R.K.; Martin J.; Mattheisen M.; Als T.D.; Agerbo E.; Baldursson G.; Belliveau R.; Bybjerg-Grauholm J.; B&#xE6;kvad-Hansen M.; Cerrato F.; Chambert K.; Churchhouse C.; Dumont A.; Eriksson N.; Gandal M.; Goldstein J.I.; Grasby K.L.; Grove J.; Gudmundsson O.O.; Hansen C.S.; Hauberg M.E.; Hollegaard M.V.; Howrigan D.P.; Huang H.; Maller J.B.; Martin A.R.; Martin N.G.; Moran J.; Pallesen J.; Palmer D.S.; Pedersen C.B.; Pedersen M.G.; Poterba T.; Poulsen J.B.; Ripke S.; Robinson E.B.; Satterstrom F.K.; Stefansson H.; Stevens C.; Turley P.; Walters G.B.; Won H.; Wright M.J.; Andreassen O.A.; Asherson P.; Burton C.L.; Boomsma D.I.; Cormand B.; Dalsgaard S.; Franke B.; Gelernter J.; Geschwind D.; Hakonarson H.; Haavik J.; Kranzler H.R.; Kuntsi J.; Langley K.; Lesch K.P.; Middeldorp C.; Reif A.; Rohde L.A.; Roussos P.; Schachar R.; Sklar P.; Sonuga-Barke E.J.S.; Sul-livan P.F.; Thapar A.; Tung J.Y.; Waldman I.D.; Medland S.E.; Stefansson K.; Nordentoft M.; Hougaard D.M.; Werge T.; Mors O.; Mortensen P.B.; Daly M.J.; Faraone S.V.; B&#xF8;rglum A.D.; Neale B.M.; Discovery of the first genome-wide significant risk loci for atten-tion deficit\/hyperactivity disorder. Nat Genet 2019,51(1),63-75","journal-title":"Nat Genet"},{"key":"ref=43","volume":"17","author":"Pirdehghan A.","year":"2015","unstructured":"Pirdehghan A.; Aghakoochak A.; Karimi M.; Kazemi L.; Relation between low birth weight with attention deficit and hyper activity dis-order in children. Majallah-i Danishgah-i Ulum-i Pizishki-i Gurgan 2015,17(2)","journal-title":"Majallah-i Danishgah-i Ulum-i Pizishki-i Gurgan"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.3991\/ijoe.v15i13.11203","volume":"15","author":"Driga A-M.","year":"2019","unstructured":"Driga A-M.; Drigas A.; ADHD in the early years: Pre-natal and early causes and alternative ways of dealing. Int J Online Biomed Engin 2019,15(13)","journal-title":"Int J Online Biomed Engin"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-244X-12-85","volume":"12","author":"Chu S-M.","year":"2012","unstructured":"Chu S-M.; Tsai M-H.; Hwang F-M.; Hsu J-F.; Huang H.R.; Huang Y-S.; The relationship between attention deficit hyperactivity disor-der and premature infants in Taiwanese: A case control study. BMC Psychiatry 2012,12(1),85","journal-title":"BMC Psychiatry"},{"key":"ref=46","first-page":"515","volume":"27","author":"Nasrollahzadeh Masoomian M.","year":"2016","unstructured":"Nasrollahzadeh Masoomian M.; Asadollahi Z.; Sepehri F.; Fatehi A.; Salehi Shahrbabaki M.H.; Bidaki R.; The relationship between attention deficit\/hyperactivity and immaturity in children ages 13-7 years old referring to health centers in the city of rafsanjan in 1392. Studies in Medical Sciences 2016,27(6),515-522","journal-title":"Studies in Medical Sciences"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/jpepsy\/jsn049","volume":"33","author":"Wallis D.","year":"2008","unstructured":"Wallis D.; Russell H.F.; Muenke M.; Review: Genetics of attention deficit\/hyperactivity disorder. J Pediatr Psychol 2008,33(10),1085-1099","journal-title":"J Pediatr Psychol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1542\/peds.2011-2199","volume":"129","author":"Millichap J.G.","year":"2012","unstructured":"Millichap J.G.; Yee M.M.; The diet factor in attention-deficit\/hyperactivity disorder. Pediatrics 2012,129(2),330-337","journal-title":"Pediatrics"},{"key":"ref=49","first-page":"138","volume":"33","author":"Cormier E.","year":"2007","unstructured":"Cormier E.; Elder J.H.; Diet and child behavior problems: Fact or fiction? Pediatr Nurs 2007,33(2),138-143","journal-title":"Pediatr Nurs"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1542\/gr.27-6-72","volume":"27","author":"Ozlem E.","year":"2012","unstructured":"Ozlem E.; What causes ADHD. AAP Grand Rounds 2012,27(6),72","journal-title":"AAP Grand Rounds"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jamapsychiatry.2015.57","volume":"72","author":"Peterson B.S.","year":"2015","unstructured":"Peterson B.S.; Rauh V.A.; Bansal R.; Hao X.; Toth Z.; Nati G.; Walsh K.; Miller R.L.; Arias F.; Semanek D.; Perera F.; Effects of prenatal exposure to air pollutants (polycyclic aromatic hydrocarbons) on the development of brain white matter, cognition, and behavior in later childhood. JAMA Psychiatry 2015,72(6),531-540","journal-title":"JAMA Psychiatry"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1289\/ehp.1307420","volume":"123","author":"Hong S-B.","year":"2015","unstructured":"Hong S-B.; Im, M.H.; Kim, J.W.; Park, E.J.; Shin, M.S.; Kim, B.N.; Yoo, H.J.; Cho, I.H.; Bhang, S.Y.; Hong, Y.C.; Cho, S.C. Environmen-tal lead exposure and attention deficit\/hyperactivity disorder symptom domains in a community sample of South Korean school-age chil-dren. Environ Health Perspect 2015,123(3),271-276","journal-title":"Environ Health Perspect"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0140-6736(05)66915-2","volume":"366","author":"Biederman J.","year":"2005","unstructured":"Biederman J.; Faraone S.V.; Attention-deficit hyperactivity disorder. Lancet 2005,366(9481),237-248","journal-title":"Lancet"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmhg.2016.04.009","volume":"18","author":"Elbaz F.","year":"2017","unstructured":"Elbaz F.; Zahra S.; Hanafy H.; Magnesium, zinc and copper estimation in children with attention deficit hyperactivity disorder (ADHD). Egypt J Med Hum Genet 2017,18(2),153-163","journal-title":"Egypt J Med Hum Genet"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e0169145","DOI":"10.1371\/journal.pone.0169145","volume":"12","author":"Wang Y.","year":"2017","unstructured":"Wang Y.; Huang L.; Zhang L.; Qu Y.; Mu D.; Iron status in attention-deficit\/hyperactivity disorder: A systematic review and meta-analysis. PLoS One 2017,12(1),e0169145","journal-title":"PLoS One"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.pnpbp.2018.11.012","volume":"90","author":"Huang Y-H.","year":"2019","unstructured":"Huang Y-H.; Zeng B-Y.; Li D-J.; Cheng Y-S.; Chen T-Y.; Liang H-Y.; Yang W-C.; Lin P-Y.; Chen Y-W.; Tseng P-T.; Lin C.H.; Sig-nificantly lower serum and hair magnesium levels in children with attention deficit hyperactivity disorder than controls: A systematic re-view and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 2019,90,134-141","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s00787-017-1058-z","volume":"27","author":"Cornu C.","year":"2018","unstructured":"Cornu C.; Mercier C.; Ginhoux T.; Masson S.; Mouchet J.; Nony P.; Kassai B.; Laudy V.; Berquin P.; Franc N.; Le Heuzey M.F.; Desombre H.; Revol O.; A double-blind placebo-controlled randomised trial of omega-3 supplementation in children with moderate ADHD symptoms. Eur Child Adolesc Psychiatry 2018,27(3),377-384","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/1028415X.2017.1331952","volume":"21","author":"San Mauro Mart&#xED;n I.","year":"2018","unstructured":"San Mauro Mart&#xED;n I.; Blumenfeld Olivares J.A.; Garicano Vilar E.; Echeverry L&#xF3;pez M.; Garc&#xED;a Bernat M.; Quevedo Santos Y.; Blanco L&#xF3;pez M.; Elortegui Pascual P.; Borregon Rivilla E.; Rinc&#xF3;n Barrado M.; Nutritional and environmental factors in attention-deficit hyper-activity disorder (ADHD): A cross-sectional study. Nutr Neurosci 2018,21(9),641-647","journal-title":"Nutr Neurosci"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/08039488.2014.921933","volume":"69","author":"Heilskov Rytter M.J.","year":"2015","unstructured":"Heilskov Rytter M.J.; Andersen L.B.B.; Houmann T.; Bilenberg N.; Hvolby A.; M&#xF8;lgaard C.; Michaelsen K.F.; Lauritzen L.; Diet in the treatment of ADHD in children - a systematic review of the literature. Nord J Psychiatry 2015,69(1),1-18","journal-title":"Nord J Psychiatry"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12888-021-03130-4","volume":"21","author":"Borge T.C.","year":"2021","unstructured":"Borge T.C.; Biele G.; Papadopoulou E.; Andersen L.F.; Jacka F.; Eggesb&#xF8; M.; Caspersen I.H.; Aase H.; Meltzer H.M.; Brants&#xE6;ter A.L.; The associations between maternal and child diet quality and child ADHD - findings from a large Norwegian pregnancy cohort study. BMC Psychiatry 2021,21(1),139","journal-title":"BMC Psychiatry"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1176\/appi.ajp.2012.12070991","volume":"170","author":"Sonuga-Barke E.J.","year":"2013","unstructured":"Sonuga-Barke E.J.; Brandeis D.; Cortese S.; Daley D.; Ferrin M.; Holtmann M.; Stevenson J.; Danckaerts M.; van der Oord S.; D&#xF6;-pfner M.; Dittmann R.W.; Simonoff E.; Zuddas A.; Banaschewski T.; Buitelaar J.; Coghill D.; Hollis C.; Konofal E.; Lecendreux M.; Wong I.C.; Sergeant J.; Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled tri-als of dietary and psychological treatments. Am J Psychiatry 2013,170(3),275-289","journal-title":"Am J Psychiatry"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11920-017-0762-1","volume":"19","author":"Lange K.W.","year":"2017","unstructured":"Lange K.W.; Hauser J.; Lange K.M.; Makulska-Gertruda E.; Nakamura Y.; Reissmann A.; Sakaue Y.; Takano T.; Takeuchi Y.; The role of nutritional supplements in the treatment of ADHD: what the evidence says. Curr Psychiatry Rep 2017,19(2),8","journal-title":"Curr Psychiatry Rep"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2478\/v10042-010-0047-6","volume":"48","author":"Tanriover G.","year":"2010","unstructured":"Tanriover G.; Seval-Celik Y.; Ozsoy O.; Akkoyunlu G.; Savcioglu F.; Hacioglu G.; Demir N.; Agar A.; The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson\u2019s disease. Folia Histochem Cytobiol 2010,48(3),434-441","journal-title":"Folia Histochem Cytobiol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.immuni.2013.05.015","volume":"38","author":"Yan Y.","year":"2013","unstructured":"Yan Y.; Jiang W.; Spinetti T.; Tardivel A.; Castillo R.; Bourquin C.; Guarda G.; Tian Z.; Tschopp J.; Zhou R.; Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 2013,38(6),1154-1163","journal-title":"Immunity"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2016.07.145","volume":"59","author":"Robertson R.C.","year":"2017","unstructured":"Robertson R.C.; Seira Oriach C.; Murphy K.; Moloney G.M.; Cryan J.F.; Dinan T.G.; Paul Ross R.; Stanton C.; Omega-3 polyunsatu-rated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain Behav Immun 2017,59,21-37","journal-title":"Brain Behav Immun"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"602","DOI":"10.3389\/fendo.2018.00602","volume":"9","author":"Very N.","year":"2018","unstructured":"Very N.; Vercoutter-Edouart A.S.; Lefebvre T.; Hardivill&#xE9; S.; El Yazidi-Belkoura I.; Cross-dysregulation of O-GlcNAcylation and PI3K\/Akt\/mTOR axis in human chronic diseases. Front Endocrinol (Lausanne) 2018,9,602","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1242\/jcs.093773","volume":"127","author":"Jean S.","year":"2014","unstructured":"Jean S.; Kiger A.A.; Classes of phosphoinositide 3-kinases at a glance. J Cell Sci 2014,127(Pt 5),923-928","journal-title":"J Cell Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jbior.2015.05.002","volume":"59","author":"Kriplani N.","year":"2015","unstructured":"Kriplani N.; Hermida M.A.; Brown E.R.; Leslie N.R.; Class I.; Class I PI 3-kinases: Function and evolution. Adv Biol Regul 2015,59,53-64","journal-title":"Adv Biol Regul"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.3390\/ijms19124098","volume":"19","author":"Maffei A.","year":"2018","unstructured":"Maffei A.; Lembo G.; Carnevale D.; PI3Kinases in Diabetes Mellitus and Its Related Complications. Int J Mol Sci 2018,19(12),4098","journal-title":"Int J Mol Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1042\/BJ20120008","volume":"443","author":"Falasca M.","year":"2012","unstructured":"Falasca M.; Maffucci T.; Regulation and cellular functions of class II phosphoinositide 3-kinases. Biochem J 2012,443(3),587-601","journal-title":"Biochem J"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"e76405","DOI":"10.1371\/journal.pone.0076405","volume":"8","author":"Devereaux K.","year":"2013","unstructured":"Devereaux K.; Dall\u2019Armi C.; Alcazar-Roman A.; Ogasawara Y.; Zhou X.; Wang F.; Yamamoto A.; De Camilli P.; Di Paolo G.; Regula-tion of mammalian autophagy by class II and III PI 3-kinases through PI3P synthesis. PLoS One 2013,8(10),e76405","journal-title":"PLoS One"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.tibs.2014.12.003","volume":"40","author":"Burke J.E.","year":"2015","unstructured":"Burke J.E.; Williams R.L.; Synergy in activating class I PI3Ks. Trends Biochem Sci 2015,40(2),88-100","journal-title":"Trends Biochem Sci"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0955-0674(99)80029-5","volume":"11","author":"Leevers S.J.","year":"1999","unstructured":"Leevers S.J.; Vanhaesebroeck B.; Waterfield M.D.; Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol 1999,11(2),219-225","journal-title":"Curr Opin Cell Biol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.bbalip.2014.09.014","volume":"1851","author":"Posor Y.","year":"2015","unstructured":"Posor Y.; Eichhorn-Gr&#xFC;nig M.; Haucke V.; Phosphoinositides in endocytosis. Biochimica Et Biophysica Acta (BBA)-. Mol Cell Biol Lipids 2015,1851(6),794-804","journal-title":"Mol Cell Biol Lipids"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1089\/ars.2006.8.1765","volume":"8","author":"Leslie N.R.","year":"2006","unstructured":"Leslie N.R.; The redox regulation of PI 3-kinase-dependent signaling. Antioxid Redox Signal 2006,8(9-10),1765-1774","journal-title":"Antioxid Redox Signal"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.1089\/ars.2010.3685","volume":"15","author":"Zhang Y.","year":"2011","unstructured":"Zhang Y.; Du Y.; Le W.; Wang K.; Kieffer N.; Zhang J.; Redox control of the survival of healthy and diseased cells. Antioxid Redox Signal 2011,15(11),2867-2908","journal-title":"Antioxid Redox Signal"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"Fruman D.A.","year":"2017","unstructured":"Fruman D.A.; Chiu H.; Hopkins B.D.; Bagrodia S.; Cantley L.C.; Abraham R.T.; The PI3K pathway in human disease. Cell 2017,170(4),605-635","journal-title":"Cell"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.2174\/1381612823666170210150147","volume":"23","author":"Chen S-P.","year":"2017","unstructured":"Chen S-P.; Zhou Y-Q.; Liu D-Q.; Zhang W.; Manyande A.; Guan X-H.; Tian Y.K.; Ye D-W.; Omar D.M.; PI3K\/Akt pathway: a poten-tial therapeutic target for chronic pain. Curr Pharm Des 2017,23(12),1860-1868","journal-title":"Curr Pharm Des"},{"key":"ref=79","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28215","author":"Wang D.","year":"2019","unstructured":"Wang D.; Zhou W.; Chen J.; Wei W.; Upstream regulators of phosphoinositide 3-kinase and their role in diseases. J Cell Physiol 2019","journal-title":"J Cell Physiol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jpain.2011.12.006","volume":"13","author":"Shih M-H.","year":"2012","unstructured":"Shih M-H.; Kao S-C.; Wang W.; Yaster M.; Tao Y-X.; Spinal cord NMDA receptor-mediated activation of mammalian target of rapamy-cin is required for the development and maintenance of bone cancer-induced pain hypersensitivities in rats. J Pain 2012,13(4),338-349","journal-title":"J Pain"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4442","DOI":"10.1073\/pnas.0914733107","volume":"107","author":"Cunha T.M.","year":"2010","unstructured":"Cunha T.M.; Roman-Campos D.; Lotufo C.M.; Duarte H.L.; Souza G.R.; Verri W.A.; Funez M.I.; Dias Q.M.; Schivo I.R.; Domingues A.C.; Sachs D.; Chiavegatto S.; Teixeira M.M.; Hothersall J.S.; Cruz J.S.; Cunha F.Q.; Ferreira S.H.; Morphine peripheral analgesia depends on activation of the PI3Kgamma\/AKT\/nNOS\/NO\/KATP signaling pathway. Proc Natl Acad Sci USA 2010,107(9),4442-4447","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/jnc.13139","volume":"134","author":"Guan X.","year":"2015","unstructured":"Guan X.; Fu Q.; Xiong B.; Song Z.; Shu B.; Bu H.; Xu B.; Manyande A.; Cao F.; Tian Y.; Activation of PI3K&#x3B3;\/Akt pathway mediates bone cancer pain in rats. J Neurochem 2015,134(3),590-600","journal-title":"J Neurochem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"ra82","DOI":"10.1126\/scisignal.aae0453","volume":"9","author":"Houslay D.M.","year":"2016","unstructured":"Houslay D.M.; Anderson K.E.; Chessa T.; Kulkarni S.; Fritsch R.; Downward J.; Backer J.M.; Stephens L.R.; Hawkins P.T.; Coinci-dent signals from GPCRs and receptor tyrosine kinases are uniquely transduced by PI3K&#x3B2; in myeloid cells. Sci Signal 2016,9(441),ra82-ra82","journal-title":"Sci Signal"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s12031-012-9822-5","volume":"49","author":"Huang W.","year":"2013","unstructured":"Huang W.; Zhao Y.; Zhu X.; Cai Z.; Wang S.; Yao S.; Qi Z.; Xie P.; Fluoxetine upregulates phosphorylated-AKT and phosphorylated-ERK1\/2 proteins in neural stem cells: evidence for a crosstalk between AKT and ERK1\/2 pathways. J Mol Neurosci 2013,49(2),244-249","journal-title":"J Mol Neurosci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.yexcr.2013.05.008","volume":"319","author":"Hong S-K.","year":"2013","unstructured":"Hong S-K.; Jeong J.H.; Chan A.M.; Park J-I.; AKT upregulates B-Raf Ser445 phosphorylation and ERK1\/2 activation in prostate cancer cells in response to androgen depletion. Exp Cell Res 2013,319(12),1732-1743","journal-title":"Exp Cell Res"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/ijc.27422","volume":"131","author":"Bonnas C.","year":"2012","unstructured":"Bonnas C.; Specht K.; Spleiss O.; Froehner S.; Dietmann G.; Kr&#xFC;ger J.M.; Arbogast S.; Feuerhake F.; Effects of cold ischemia and inflammatory tumor microenvironment on detection of PI3K\/AKT and MAPK pathway activation patterns in clinical cancer samples. Int J Cancer 2012,131(7),1621-1632","journal-title":"Int J Cancer"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/978-3-319-42118-6_3","author":"Lien E.C.","year":"2016","unstructured":"Lien E.C.; Lyssiotis C.A.; Cantley L.C.;  Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer Metabol Cancer 2016,39-72","journal-title":"Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer Metabol Cancer"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fonc.2018.00160","volume":"8","author":"Koundouros N.","year":"2018","unstructured":"Koundouros N.; Poulogiannis G.; Phosphoinositide 3-kinase\/Akt signaling and redox metabolism in cancer. Front Oncol 2018,8,160","journal-title":"Front Oncol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature12912","volume":"505","author":"Lawrence M.S.","year":"2014","unstructured":"Lawrence M.S.; Stojanov P.; Mermel C.H.; Robinson J.T.; Garraway L.A.; Golub T.R.; Meyerson M.; Gabriel S.B.; Lander E.S.; Getz G.; Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014,505(7484),495-501","journal-title":"Nature"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrg1879","volume":"7","author":"Engelman J.A.","year":"2006","unstructured":"Engelman J.A.; Luo J.; Cantley L.C.; The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 2006,7(8),606-619","journal-title":"Nat Rev Genet"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2017.04.001","volume":"169","author":"Manning B.D.","year":"2017","unstructured":"Manning B.D.; Toker A.; AKT\/PKB signaling: navigating the network. Cell 2017,169(3),381-405","journal-title":"Cell"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0959-4388(00)00211-7","volume":"11","author":"Brunet A.","year":"2001","unstructured":"Brunet A.; Datta S.R.; Greenberg M.E.; Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr Opin Neurobiol 2001,11(3),297-305","journal-title":"Curr Opin Neurobiol"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.cell.2006.08.033","volume":"127","author":"Jacinto E.","year":"2006","unstructured":"Jacinto E.; Facchinetti V.; Liu D.; Soto N.; Wei S.; Jung S.Y.; Huang Q.; Qin J.; Su B.; SIN1\/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell 2006,127(1),125-137","journal-title":"Cell"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/nm1337","volume":"12","author":"Thomas G.V.","year":"2006","unstructured":"Thomas G.V.; Tran C.; Mellinghoff I.K.; Welsbie D.S.; Chan E.; Fueger B.; Czernin J.; Sawyers C.L.; Hypoxia-inducible factor deter-mines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 2006,12(1),122-127","journal-title":"Nat Med"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1159\/000485360","volume":"44","author":"Wang H.","year":"2017","unstructured":"Wang H.; Deng X.; Zhang J.; Ou Z.; Mai J.; Ding S.; Huo S.; Elevated expression of zinc finger protein 703 promotes cell proliferation and metastasis through PI3K\/AKT\/GSK-3&#x3B2; signalling in oral squamous cell carcinoma. Cell Physiol Biochem 2017,44(3),920-934","journal-title":"Cell Physiol Biochem"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1111\/j.1460-9568.2006.04859.x","volume":"23","author":"Horwood J.M.","year":"2006","unstructured":"Horwood J.M.; Dufour F.; Laroche S.; Davis S.; Signalling mechanisms mediated by the phosphoinositide 3-kinase\/Akt cascade in syn-aptic plasticity and memory in the rat. Eur J Neurosci 2006,23(12),3375-3384","journal-title":"Eur J Neurosci"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.neuroscience.2016.06.046","volume":"332","author":"Kocsis K.","year":"2016","unstructured":"Kocsis K.; Frank R.; Szab&#xF3; J.; Knapp L.; Kis Z.; Farkas T.; V&#xE9;csei L.; Toldi J.; Acetyl-l-carnitine restores synaptic transmission and enhances the inducibility of stable LTP after oxygen-glucose deprivation. Neuroscience 2016,332,203-211","journal-title":"Neuroscience"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"Saxton R.A.","year":"2017","unstructured":"Saxton R.A.; Sabatini D.M.; mTOR signaling in growth, metabolism, and disease. Cell 2017,168(6),960-976","journal-title":"Cell"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tcb.2015.06.002","volume":"25","author":"Dibble C.C.","year":"2015","unstructured":"Dibble C.C.; Cantley L.C.; Regulation of mTORC1 by PI3K signaling. Trends Cell Biol 2015,25(9),545-555","journal-title":"Trends Cell Biol"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20110892","volume":"441","author":"Magnuson B.","year":"2012","unstructured":"Magnuson B.; Ekim B.; Fingar D.C.; Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signalling networks. Biochem J 2012,441(1),1-21","journal-title":"Biochem J"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1078-0432.CCR-14-2362","volume":"23","author":"Malka-Mahieu H.","year":"2017","unstructured":"Malka-Mahieu H.; Newman M.; D&#xE9;saubry L.; Robert C.; Vagner S.; Molecular pathways: the eIF4F translation initiation complex\u2014new opportunities for cancer treatment. Clin Cancer Res 2017,23(1),21-25","journal-title":"Clin Cancer Res"},{"key":"ref=102","first-page":"281","volume":"5","author":"Bruhn M.A.","year":"2013","unstructured":"Bruhn M.A.; Pearson R.B.; Hannan R.D.; Sheppard K.E.; AKT-independent PI3-K signaling in cancer - emerging role for SGK3. Cancer Manag Res 2013,5,281-292","journal-title":"Cancer Manag Res"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.molmet.2016.06.004","volume":"5","author":"Sohn J-W.","year":"2016","unstructured":"Sohn J-W.; Oh Y.; Kim K.W.; Lee S.; Williams K.W.; Elmquist J.K.; Leptin and insulin engage specific PI3K subunits in hypothalamic SF1 neurons. Mol Metab 2016,5(8),669-679","journal-title":"Mol Metab"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.4161\/cc.21572","volume":"11","author":"Troutman T.D.","year":"2012","unstructured":"Troutman T.D.; Bazan J.F.; Pasare C.; Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle 2012,11(19),3559-3567","journal-title":"Cell Cycle"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2426","volume":"13","author":"Aksoy E.","year":"2012","unstructured":"Aksoy E.; Taboubi S.; Torres D.; Delbauve S.; Hachani A.; Whitehead M.A.; Pearce W.P.; Berenjeno I.M.; Nock G.; Filloux A.; Beyaert R.; Flamand V.; Vanhaesebroeck B.; The p110&#x3B4; isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock. Nat Immunol 2012,13(11),1045-1054","journal-title":"Nat Immunol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3109\/08923973.2012.665461","volume":"34","author":"Saponaro C.","year":"2012","unstructured":"Saponaro C.; Cianciulli A.; Calvello R.; Dragone T.; Iacobazzi F.; Panaro M.A.; The PI3K\/Akt pathway is required for LPS activation of microglial cells. Immunopharmacol Immunotoxicol 2012,34(5),858-865","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2014.03.039","volume":"269","author":"Zhao M.","year":"2014","unstructured":"Zhao M.; Zhou A.; Xu L.; Zhang X.; The role of TLR4-mediated PTEN\/PI3K\/AKT\/NF-&#x3BA;B signaling pathway in neuroinflammation in hippocampal neurons. Neuroscience 2014,269,93-101","journal-title":"Neuroscience"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.4049\/jimmunol.172.11.7015","volume":"172","author":"Kim W-K.","year":"2004","unstructured":"Kim W-K.; Hwang S-Y.; Oh E-S.; Piao H.Z.; Kim K-W.; Han I-O.; TGF-&#x3B2;1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity. J Immunol 2004,172(11),7015-7023","journal-title":"J Immunol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12975-016-0460-z","volume":"8","author":"Koh S-H.","year":"2017","unstructured":"Koh S-H.; Park H-H.; Neurogenesis in stroke recovery. Transl Stroke Res 2017,8(1),3-13","journal-title":"Transl Stroke Res"},{"key":"ref=110","first-page":"59","volume":"2","author":"Gonzalez-Perez O.","year":"2012","unstructured":"Gonzalez-Perez O.; Neural stem cells in the adult human brain. Biol Biomed Rep 2012,2(1),59-69","journal-title":"Biol Biomed Rep"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3988\/jcn.2015.11.4.297","volume":"11","author":"Koh S-H.","year":"2015","unstructured":"Koh S-H.; Lo E.H.; The role of the PI3K pathway in the regeneration of the damaged brain by neural stem cells after cerebral infarction. J Clin Neurol 2015,11(4),297-304","journal-title":"J Clin Neurol"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng.2331","volume":"44","author":"Rivi&#xE8;re J-B.","year":"2012","unstructured":"Rivi&#xE8;re J-B.; Mirzaa G.M.; O\u2019Roak B.J.; Beddaoui M.; Alcantara D.; Conway R.L.; St-Onge J.; Schwartzentruber J.A.; Gripp K.W.; Nikkel S.M.; Worthylake T.; Sullivan C.T.; Ward T.R.; Butler H.E.; Kramer N.A.; Albrecht B.; Armour C.M.; Armstrong L.; Caluseriu O.; Cytrynbaum C.; Drolet B.A.; Innes A.M.; Lauzon J.L.; Lin A.E.; Mancini G.M.; Meschino W.S.; Reggin J.D.; Saggar A.K.; Lerman-Sagie T.; Uyanik G.; Weksberg R.; Zirn B.; Beaulieu C.L.; Majewski J.; Bulman D.E.; O\u2019Driscoll M.; Shendure J.; Gra-ham J.M.; Boycott K.M.; Dobyns W.B.; De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spec-trum of related megalencephaly syndromes. Nat Genet 2012,44(8),934-940","journal-title":"Nat Genet"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/brain\/awv045","volume":"138","author":"Jansen L.A.","year":"2015","unstructured":"Jansen L.A.; Mirzaa G.M.; Ishak G.E.; O\u2019Roak B.J.; Hiatt J.B.; Roden W.H.; Gunter S.A.; Christian S.L.; Collins S.; Adams C.; Rivi-&#xE8;re J.B.; St-Onge J.; Ojemann J.G.; Shendure J.; Hevner R.F.; Dobyns W.B.; PI3K\/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 2015,138(Pt 6),1613-1628","journal-title":"Brain"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.jneuroim.2015.04.003","volume":"282","author":"Xiao Z.","year":"2015","unstructured":"Xiao Z.; Peng J.; Yang L.; Kong H.; Yin F.; Interleukin-1&#x3B2; plays a role in the pathogenesis of mesial temporal lobe epilepsy through the PI3K\/Akt\/mTOR signaling pathway in hippocampal neurons. J Neuroimmunol 2015,282,110-117","journal-title":"J Neuroimmunol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.neuropharm.2018.08.002","volume":"140","author":"Brandt C.","year":"2018","unstructured":"Brandt C.; Hillmann P.; Noack A.; R&#xF6;mermann K.; &#xD6;hler L.A.; Rageot D.; Beaufils F.; Melone A.; Sele A.M.; Wymann M.P.; Fab-bro D.; L&#xF6;scher W.; The novel, catalytic mTORC1\/2 inhibitor PQR620 and the PI3K\/mTORC1\/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy. Neuropharmacology 2018,140,107-120","journal-title":"Neuropharmacology"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","volume":"26","author":"Heras-Sandoval D.","year":"2014","unstructured":"Heras-Sandoval D.; P&#xE9;rez-Rojas J.M.; Hern&#xE1;ndez-Dami&#xE1;n J.; Pedraza-Chaverri J.; The role of PI3K\/AKT\/mTOR pathway in the modula-tion of autophagy and the clearance of protein aggregates in neurodegeneration. Cell Signal 2014,26(12),2694-2701","journal-title":"Cell Signal"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3389\/fnins.2018.00073","volume":"12","author":"Yang L.","year":"2018","unstructured":"Yang L.; Wang H.; Liu L.; Xie A.; The role of insulin\/IGF-1\/PI3K\/Akt\/GSK3&#x3B2; signaling in Parkinson\u2019s disease dementia. Front Neurosci 2018,12,73","journal-title":"Front Neurosci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.brainres.2018.05.023","volume":"1692","author":"Li S.","year":"2018","unstructured":"Li S.; Chen X.; Mao L.; Zahid K.R.; Wen J.; Zhang L.; Zhang M.; Duan J.; Duan J.; Yin X.; Wang Y.; Zhao L.; Tang X.; Wang X.; Xu G.; Histone deacetylase 1 promotes glioblastoma cell proliferation and invasion via activation of PI3K\/AKT and MEK\/ERK signaling pathways. Brain Res 2018,1692,154-162","journal-title":"Brain Res"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1093\/neuonc\/noy068","volume":"20","author":"Daniel P.M.","year":"2018","unstructured":"Daniel P.M.; Filiz G.; Brown D.V.; Christie M.; Waring P.M.; Zhang Y.; Haynes J.M.; Pouton C.; Flanagan D.; Vincan E.; Johns T.G.; Montgomery K.; Phillips W.A.; Mantamadiotis T.; PI3K activation in neural stem cells drives tumorigenesis which can be amelio-rated by targeting the cAMP response element binding protein. Neuro-oncol 2018,20(10),1344-1355","journal-title":"Neuro-oncol"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1002\/ijc.27935","volume":"132","author":"Seitz C.","year":"2013","unstructured":"Seitz C.; Hugle M.; Cristofanon S.; Tchoghandjian A.; Fulda S.; The dual PI3K\/mTOR inhibitor NVP-BEZ235 and chloroquine syner-gize to trigger apoptosis via mitochondrial-lysosomal cross-talk. Int J Cancer 2013,132(11),2682-2693","journal-title":"Int J Cancer"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"e1084","DOI":"10.1038\/cddis.2014.69","volume":"5","author":"Liu Q.","year":"2014","unstructured":"Liu Q.; Qiu J.; Liang M.; Golinski J.; van Leyen K.; Jung J.E.; You Z.; Lo E.H.; Degterev A.; Whalen M.J.; Akt and mTOR mediate programmed necrosis in neurons. Cell Death Dis 2014,5(2),e1084-e1084","journal-title":"Cell Death Dis"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.freeradbiomed.2014.06.023","volume":"74","author":"Ribeiro M.","year":"2014","unstructured":"Ribeiro M.; Rosenstock T.R.; Oliveira A.M.; Oliveira C.R.; Rego A.C.; Insulin and IGF-1 improve mitochondrial function in a PI-3K\/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington\u2019s disease knock-in striatal cells. Free Radic Biol Med 2014,74,129-144","journal-title":"Free Radic Biol Med"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1016\/j.bbamcr.2016.09.003","volume":"1863","author":"Kim D.I.","year":"2016","unstructured":"Kim D.I.; Lee, K.H.; Gabr, A.A.; Choi, G.E.; Kim, J.S.; Ko, S.H.; Han, H.J. A&#x3B2;-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis. Biochim Biophys Acta 2016,1863(11),2820-2834","journal-title":"Biochim Biophys Acta"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1096\/fj.05-4829fje","volume":"20","author":"Kilic E.","year":"2006","unstructured":"Kilic E.; Kilic U.; Wang Y.; Bassetti C.L.; Marti H.H.; Hermann D.M.; The phosphatidylinositol-3 kinase\/Akt pathway mediates VEGF\u2019s neuroprotective activity and induces blood brain barrier permeability after focal cerebral ischemia. FASEB J 2006,20(8),1185-1187","journal-title":"FASEB J"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1007\/s11064-008-9848-9","volume":"34","author":"Nguyen N.","year":"2009","unstructured":"Nguyen N.; Lee S.B.; Lee Y.S.; Lee K-H.; Ahn J-Y.; Neuroprotection by NGF and BDNF against neurotoxin-exerted apoptotic death in neural stem cells are mediated through Trk receptors, activating PI3-kinase and MAPK pathways. Neurochem Res 2009,34(5),942-951","journal-title":"Neurochem Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1096\/fj.02-0738com","volume":"17","author":"Ha K-S.","year":"2003","unstructured":"Ha K-S.; Kim K-M.; Kwon Y-G.; Bai S-K.; Nam W-D.; Yoo Y-M.; Kim P.K.; Chung H-T.; Billiar T.R.; Kim Y-M.; Nitric oxide pre-vents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase\/Akt activation. FASEB J 2003,17(9),1036-1047","journal-title":"FASEB J"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1523\/JNEUROSCI.20-08-02875.2000","volume":"20","author":"Namikawa K.","year":"2000","unstructured":"Namikawa K.; Honma M.; Abe K.; Takeda M.; Mansur K.; Obata T.; Miwa A.; Okado H.; Kiyama H.; Akt\/protein kinase B prevents injury-induced motoneuron death and accelerates axonal regeneration. J Neurosci 2000,20(8),2875-2886","journal-title":"J Neurosci"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.tox.2009.09.011","volume":"265","author":"Park H-H.","year":"2009","unstructured":"Park H-H.; Lee K-Y.; Kim S.H.; Lee Y.J.; Koh S-H.; L-DOPA-induced neurotoxicity is reduced by the activation of the PI3K signaling pathway. Toxicology 2009,265(3),80-86","journal-title":"Toxicology"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.bbrc.2017.01.069","volume":"485","author":"Zheng R.","year":"2017","unstructured":"Zheng R.; Zhang Z-H.; Chen C.; Chen Y.; Jia S-Z.; Liu Q.; Ni J-Z.; Song G-L.; Selenomethionine promoted hippocampal neurogenesis via the PI3K-Akt-GSK3&#x3B2;-Wnt pathway in a mouse model of Alzheimer\u2019s disease. Biochem Biophys Res Commun 2017,485(1),6-15","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"10390","DOI":"10.1523\/JNEUROSCI.0546-15.2015","volume":"35","author":"Huang L.","year":"2015","unstructured":"Huang L.; Sherchan P.; Wang Y.; Reis C.; Applegate R.L.; Tang J.; Zhang J.H.; Phosphoinositide 3-kinase gamma contributes to neuroinflammation in a rat model of surgical brain injury. J Neurosci 2015,35(29),10390-10401","journal-title":"J Neurosci"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/cne.23452","volume":"522","author":"Ribic A.","year":"2014","unstructured":"Ribic A.; Liu X.; Crair M.C.; Biederer T.; Structural organization and function of mouse photoreceptor ribbon synapses involve the im-munoglobulin protein synaptic cell adhesion molecule 1. J Comp Neurol 2014,522(4),900-920","journal-title":"J Comp Neurol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"e82894","DOI":"10.1371\/journal.pone.0082894","volume":"9","author":"Murakami S.","year":"2014","unstructured":"Murakami S.; Sakurai-Yageta M.; Maruyama T.; Murakami Y.; Trans-homophilic interaction of CADM1 activates PI3K by forming a complex with MAGuK-family proteins MPP3 and Dlg. PLoS One 2014,9(2),e82894","journal-title":"PLoS One"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jchemneu.2009.08.004","volume":"38","author":"Ugrumov M.V.","year":"2009","unstructured":"Ugrumov M.V.; Non-dopaminergic neurons partly expressing dopaminergic phenotype: distribution in the brain, development and func-tional significance. J Chem Neuroanat 2009,38(4),241-256","journal-title":"J Chem Neuroanat"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.bbrc.2008.05.091","volume":"372","author":"Lute B.J.","year":"2008","unstructured":"Lute B.J.; Khoshbouei H.; Saunders C.; Sen N.; Lin R.Z.; Javitch J.A.; Galli A.; PI3K signaling supports amphetamine-induced dopa-mine efflux. Biochem Biophys Res Commun 2008,372(4),656-661","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.psyneuen.2010.12.007","volume":"36","author":"Bourque M.","year":"2011","unstructured":"Bourque M.; Liu B.; Dluzen D.E.; Di Paolo T.; Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Psychoneuroendocrinology 2011,36(7),955-969","journal-title":"Psychoneuroendocrinology"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1046\/j.1471-4159.2002.00892.x","volume":"81","author":"Carvelli L.","year":"2002","unstructured":"Carvelli L.; Mor&#xF3;n J.A.; Kahlig K.M.; Ferrer J.V.; Sen N.; Lechleiter J.D.; Leeb-Lundberg L.M.; Merrill G.; Lafer E.M.; Ballou L.M.; Shippenberg T.S.; Javitch J.A.; Lin R.Z.; Galli A.; PI 3-kinase regulation of dopamine uptake. J Neurochem 2002,81(4),859-869","journal-title":"J Neurochem"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S1471-4914(01)02107-4","volume":"7","author":"Weaver S.A.","year":"2001","unstructured":"Weaver S.A.; Ward S.G.; Phosphoinositide 3-kinases in the gut: a link between inflammation and cancer? Trends Mol Med 2001,7(10),455-462","journal-title":"Trends Mol Med"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10571-012-9897-0","volume":"33","author":"Lv T.","year":"2013","unstructured":"Lv T.; Wang S-D.; Bai J.; Thioredoxin-1 was required for CREB activity by methamphetamine in rat pheochromocytoma cells. Cell Mol Neurobiol 2013,33(3),319-325","journal-title":"Cell Mol Neurobiol"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1007\/s00213-016-4231-z","volume":"233","author":"Hong S-I.","year":"2016","unstructured":"Hong S-I.; Kim M-J.; You I-J.; Kwon S-H.; Ma S-X.; Hwang J-Y.; Seo J-Y.; Ko Y-H.; Lee B.R.; Lee S-Y.; Jang C-G.; Phentermine induces conditioned rewarding effects via activation of the PI3K\/Akt signaling pathway in the nucleus accumbens. Psychopharmacology (Berl) 2016,233(8),1405-1413","journal-title":"Psychopharmacology (Berl)"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41398-019-0619-y","volume":"9","author":"Ulke C.","year":"2019","unstructured":"Ulke C.; Rullmann M.; Huang J.; Luthardt J.; Becker G-A.; Patt M.; Meyer P.M.; Tiepolt S.; Hesse S.; Sabri O.; Strau&#xDF; M.; Adult attention-deficit\/hyperactivity disorder is associated with reduced norepinephrine transporter availability in right attention networks: a (S,S)-O-[11C]methylreboxetine positron emission tomography study. Transl Psychiatry 2019,9(1),301","journal-title":"Transl Psychiatry"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12991-021-00330-w","volume":"20","author":"Sukmajaya A.C.","year":"2021","unstructured":"Sukmajaya A.C.; Lusida M.I.; Soetjipto; Setiawati, Y. Systematic review of gut microbiota and attention-deficit hyperactivity disorder (ADHD). Ann Gen Psychiatry 2021,20(1),12","journal-title":"Ann Gen Psychiatry"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0166-4328(01)00417-X","volume":"130","author":"Andersen S.L.","year":"2002","unstructured":"Andersen S.L.; Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention defi-cit\/hyperactivity disorder (ADHD). Behav Brain Res 2002,130(1-2),197-201","journal-title":"Behav Brain Res"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.pnpbp.2019.03.021","volume":"93","author":"Fraporti T.T.","year":"2019","unstructured":"Fraporti T.T.; Contini V.; Tovo-Rodrigues L.; Recamonde-Mendoza M.; Rovaris D.L.; Rohde L.A.; Hutz M.H.; Salatino-Oliveira A.; Genro J.P.; Synergistic effects between ADORA2A and DRD2 genes on anxiety disorders in children with ADHD. Prog Neuropsychopharmacol Biol Psychiatry 2019,93,214-220","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bcp.2018.08.015","volume":"156","author":"Zhang X.","year":"2018","unstructured":"Zhang X.; Du Q.; Yang Y.; Wang J.; Liu Y.; Zhao Z.; Zhu Y.; Liu C.; Salidroside alleviates ischemic brain injury in mice with ischem-ic stroke through regulating BDNK mediated PI3K\/Akt pathway. Biochem Pharmacol 2018,156,99-108","journal-title":"Biochem Pharmacol"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2174\/18715206113139990130","volume":"13","author":"Sun H.","year":"2013","unstructured":"Sun H.; Wang Z.; Sebastian Yakisich J.; Natural products targeting autophagy via the PI3K\/Akt\/mTOR pathway as anticancer agents. Anticancer Agents Med Chem 2013,13(7),1048-1056","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.chroma.2012.05.081","volume":"1248","author":"Funaya N.","year":"2012","unstructured":"Funaya N.; Haginaka J.; Matrine- and oxymatrine-imprinted monodisperse polymers prepared by precipitation polymerization and their applications for the selective extraction of matrine-type alkaloids from Sophora flavescens Aiton. J Chromatogr A 2012,1248,18-23","journal-title":"J Chromatogr A"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"104541","DOI":"10.1016\/j.phrs.2019.104541","volume":"151","author":"Lan X.","year":"2020","unstructured":"Lan X.; Zhao J.; Zhang Y.; Chen Y.; Liu Y.; Xu F.; Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside. Pharmacol Res 2020,151,104541","journal-title":"Pharmacol Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"172717","DOI":"10.1016\/j.ejphar.2019.172717","volume":"864","author":"Wu B.","year":"2019","unstructured":"Wu B.; Yue H.; Zhou G.H.; Zhu Y.Y.; Wu T.H.; Wen J.F.; Cho K.W.; Jin S.N.; Protective effects of oxymatrine on homocysteine-induced endothelial injury: Involvement of mitochondria-dependent apoptosis and Akt-eNOS-NO signaling pathways. Eur J Pharmacol 2019,864,172717","journal-title":"Eur J Pharmacol"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"153505","DOI":"10.1016\/j.phymed.2021.153505","volume":"84","author":"Jiao-Yan Y.","year":"2021","unstructured":"Jiao-Yan Y.; Qing-Qing L.; Xi L.; Mei Z.; Ting S.; Na H.; Wei J.; Rui-Tao Z.; Peng Y.; Qi Y.; Oxymatrine improves blood-brain bar-rier integrity after cerebral ischemia-reperfusion injury by downregulating CAV1 and MMP9 expression. Phytomedicine 2021,84,153505","journal-title":"Phytomedicine"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"116444","DOI":"10.1016\/j.lfs.2019.04.070","volume":"254","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Wang H.; Liu N.; Du J.; Lan X.; Qi X.; Zhuang C.; Sun T.; Li Y.; Yu J.; Oxymatrine protects neonatal rat against hypoxic-ischemic brain damage via PI3K\/Akt\/GSK3&#x3B2; pathway. Life Sci 2020,254,116444","journal-title":"Life Sci"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"538059","DOI":"10.1155\/2014\/538059","volume":"2014","author":"Zhao J.","year":"2014","unstructured":"Zhao J.; Shi Z.; Liu S.; Li J.; Huang W.; Ginsenosides Rg1 from Panax ginseng: a potential therapy for acute liver failure patients? Evid Based Complement Alternat Med 2014,2014,538059","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1007\/s11064-018-2538-3","volume":"43","author":"Tu L.","year":"2018","unstructured":"Tu L.; Wang Y.; Chen D.; Xiang P.; Shen J.; Li Y.; Wang S.; Protective effects of notoginsenoside r1 via regulation of the pi3k-akt-mtor\/jnk pathway in neonatal cerebral hypoxic\u2013ischemic brain injury. Neurochem Res 2018,43(6),1210-1226","journal-title":"Neurochem Res"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1039\/C4NP00130C","volume":"32","author":"AlQathama A.","year":"2015","unstructured":"AlQathama A.; Prieto J.M.; Natural products with therapeutic potential in melanoma metastasis. Nat Prod Rep 2015,32(8),1170-1182","journal-title":"Nat Prod Rep"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnagi.2019.00155","volume":"11","author":"Ayaz M.","year":"2019","unstructured":"Ayaz M.; Sadiq A.; Junaid M.; Ullah F.; Ovais M.; Ullah I.; Ahmed J.; Shahid M.; Flavonoids as prospective neuroprotectants and their therapeutic propensity in aging associated neurological disorders. Front Aging Neurosci 2019,11,155","journal-title":"Front Aging Neurosci"},{"key":"ref=155","first-page":"3239","volume":"17","author":"Chen X.","year":"2018","unstructured":"Chen X.; Gu N.; Xue C.; Li B.R.; Plant flavonoid taxifolin inhibits the growth, migration and invasion of human osteosarcoma cells. Mol Med Rep 2018,17(2),3239-3245","journal-title":"Mol Med Rep"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"643357","DOI":"10.3389\/fphar.2021.643357","volume":"12","author":"Saito S.","year":"2021","unstructured":"Saito S.; Tanaka M.; Satoh-Asahara N.; Carare R.O.; Ihara M.; Taxifolin: a potential therapeutic agent for cerebral amyloid angiopathy. Front Pharmacol 2021,12,643357","journal-title":"Front Pharmacol"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1158\/1940-6207.CAPR-11-0397","volume":"5","author":"Oi N.","year":"2012","unstructured":"Oi N.; Chen H.; Ok Kim M.; Lubet R.A.; Bode A.M.; Dong Z.; Taxifolin suppresses UV-induced skin carcinogenesis by targeting EGFR and PI3K. Cancer Prev Res (Phila) 2012,5(9),1103-1114","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.fitote.2016.09.011","volume":"115","author":"He M.","year":"2016","unstructured":"He M.; Min J-W.; Kong W-L.; He X-H.; Li J-X.; Peng B-W.; A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia 2016,115,74-85","journal-title":"Fitoterapia"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40659-019-0214-y","volume":"52","author":"Liu X.","year":"2019","unstructured":"Liu X.; Jiang Q.; Liu H.; Luo S.; Vitexin induces apoptosis through mitochondrial pathway and PI3K\/Akt\/mTOR signaling in human non-small cell lung cancer A549 cells. Biol Res 2019,52(1),7","journal-title":"Biol Res"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"1320423","DOI":"10.1155\/2016\/1320423","volume":"2016","author":"Ahn J.","year":"2016","unstructured":"Ahn J.; Ahn H.S.; Cheong J.H.; Pe&#xF1;a I.D.; Natural product-derived treatments for attention-deficit\/hyperactivity disorder: safety, effica-cy, and therapeutic potential of combination therapy. Neural Plast 2016,2016,1320423","journal-title":"Neural Plast"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.3390\/ijms21093365","volume":"21","author":"Pham H.T.N.","year":"2020","unstructured":"Pham H.T.N.; Tran H.N.; Nguyen P.T.; Le X.T.; Nguyen K.M.; Phan S.V.; Yoneyama M.; Ogita K.; Yamaguchi T.; Folk W.R.; Ya-maguchi M.; Matsumoto K.; Bacopa monnieri (L.) Wettst. Extract improves memory performance via promotion of neurogenesis in the hippocampal dentate gyrus of adolescent mice. Int J Mol Sci 2020,21(9),3365","journal-title":"Int J Mol Sci"},{"key":"ref=162","first-page":"20","volume":"67","author":"Petcharat K.","year":"2015","unstructured":"Petcharat K.; Singh M.; Ingkaninan K.; Attarat J.; Yasothornsrikul S.; Bacopa monnieri protects SH-SY5Y cells against tert-Butyl hy-droperoxide-induced cell death via the ERK and PI3K pathways. Siriraj Med J 2015,67(1),20-26","journal-title":"Siriraj Med J"},{"key":"ref=163","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jep.2015.01.041","volume":"164","author":"Le X.T.","year":"2015","unstructured":"Le X.T.; Nguyet Pham H.T.; Van Nguyen T.; Minh Nguyen K.; Tanaka K.; Fujiwara H.; Matsumoto K.; Protective effects of Bacopa monnieri on ischemia-induced cognitive deficits in mice: the possible contribution of bacopaside I and underlying mechanism. J Ethnopharmacol 2015,164,37-45","journal-title":"J Ethnopharmacol"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1016\/j.ijbiomac.2018.07.085","volume":"118","author":"Liu P-K.","year":"2018","unstructured":"Liu P-K.; Weng Z-M.; Ge G-B.; Li H-L.; Ding L-L.; Dai Z-R.; Hou X-D.; Leng Y-H.; Yu Y.; Hou J.; Biflavones from Ginkgo\nbiloba as novel pancreatic lipase inhibitors: Inhibition potentials\nand mechanism. Int J Biol Macromol 2018,118(Pt B),2216-2223","journal-title":"Int J Biol Macromol"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"e0225761","DOI":"10.1371\/journal.pone.0225761","volume":"14","author":"Lejri I.","year":"2019","unstructured":"Lejri I.; Grimm A.; Eckert A.; Ginkgo biloba extract increases neurite outgrowth and activates the Akt\/mTOR pathway. PLoS One 2019,14(12),e0225761","journal-title":"PLoS One"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.nbd.2012.01.006","volume":"46","author":"Nada S.E.","year":"2012","unstructured":"Nada S.E.; Shah Z.A.; Preconditioning with Ginkgo biloba (EGb 761&#xAE;) provides neuroprotection through HO1 and CRMP2. Neurobiol Dis 2012,46(1),180-189","journal-title":"Neurobiol Dis"},{"key":"ref=167","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s12035-013-8572-x","volume":"49","author":"Nada S.E.","year":"2014","unstructured":"Nada S.E.; Tulsulkar J.; Shah Z.A.; Heme oxygenase 1-mediated neurogenesis is enhanced by Ginkgo biloba (EGb 761&#xAE;) after perma-nent ischemic stroke in mice. Mol Neurobiol 2014,49(2),945-956","journal-title":"Mol Neurobiol"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fnagi.2015.00129","volume":"7","author":"Ong W-Y.","year":"2015","unstructured":"Ong W-Y.; Farooqui T.; Koh H-L.; Farooqui A.A.; Ling E-A.; Protective effects of ginseng on neurological disorders. Front Aging Neurosci 2015,7,129","journal-title":"Front Aging Neurosci"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jgr.2014.06.005","volume":"39","author":"Nguyen C.T.","year":"2015","unstructured":"Nguyen C.T.; Luong T.T.; Kim G-L.; Pyo S.; Rhee D-K.; Korean red ginseng inhibits apoptosis in neuroblastoma cells via estrogen receptor &#x3B2;-mediated phosphatidylinositol-3 kinase\/Akt signaling. J Ginseng Res 2015,39(1),69-75","journal-title":"J Ginseng Res"},{"key":"ref=170","first-page":"1","volume":"17","author":"Razlog R.","year":"2011","unstructured":"Razlog R.; Pellow J.; White S.J.; A pilot study on the efficacy of Valeriana officinalis mother tincture and Valeriana officinalis 3X in the treatment of attention deficit hyperactivity disorder. Health SA Gesondheid 2011,17(1),1-7","journal-title":"Health SA Gesondheid"},{"key":"ref=171","first-page":"323","volume":"16","author":"Pellow J.","year":"2011","unstructured":"Pellow J.; Solomon E.M.; Barnard C.N.; Complementary and alternative medical therapies for children with attention-deficit\/hyperactivity disorder (ADHD). Altern Med Rev 2011,16(4),323-337","journal-title":"Altern Med Rev"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1089\/cap.2007.018","volume":"17","author":"Arnold L.E.","year":"2007","unstructured":"Arnold L.E.; Amato A.; Bozzolo H.; Hollway J.; Cook A.; Ramadan Y.; Crowl L.; Zhang D.; Thompson S.; Testa G.; Kliewer V.; Wigal T.; McBurnett K.; Manos M.; Acetyl-L-carnitine (ALC) in attention-deficit\/hyperactivity disorder: a multi-site, placebo-controlled pilot trial. J Child Adolesc Psychopharmacol 2007,17(6),791-802","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s10571-015-0227-1","volume":"36","author":"Zhang L.","year":"2016","unstructured":"Zhang L.; Ding K.; Wang H.; Wu Y.; Xu J.; Traumatic brain injury-induced neuronal apoptosis is reduced through modulation of PI3K and autophagy pathways in mouse by FTY720. Cell Mol Neurobiol 2016,36(1),131-142","journal-title":"Cell Mol Neurobiol"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1111\/bph.12667","volume":"171","author":"Chu S.","year":"2014","unstructured":"Chu S.; Chen P.; Hsieh Y.; Yu C.; Lin M.; Lin Y.; Kuo D.; Involvement of hypothalamic PI3K-STAT3 signalling in regulating amphet-amine-mediated appetite suppression. Br J Pharmacol 2014,171,3223-3233","journal-title":"Br J Pharmacol"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4306\/pi.2018.15.1.90","volume":"15","author":"Joo S.W.","year":"2018","unstructured":"Joo S.W.; Kim H-W.; Treatment of children and adolescents with attention deficit hyperactivity disorder and\/or Tourette\u2019s disorder with clonidine extended release. Psychiatry Investig 2018,15(1),90-93","journal-title":"Psychiatry Investig"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1248\/bpb.b18-00800","volume":"42","author":"Takenouchi Y.","year":"2019","unstructured":"Takenouchi Y.; Tsuboi K.; Ohsuka K.; Nobe K.; Ohtake K.; Okamoto Y.; Kasono K.; Chronic treatment with &#x3B1;-lipoic acid improves endothelium-dependent vasorelaxation of aortas in high-fat diet-fed mice. Biol Pharm Bull 2019,42(9),1456-1463","journal-title":"Biol Pharm Bull"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jddst.2016.12.012","volume":"37","author":"Tandel H.","year":"2017","unstructured":"Tandel H.; Shah D.; Vanza J.; Misra A.; Lipid based formulation approach for BCS class-II drug: Modafinil in the treatment of ADHD. J Drug Deliv Sci Technol 2017,37,166-183","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1111\/bph.14626","volume":"176","author":"Cao Y.","year":"2019","unstructured":"Cao Y.; Li Q.; Liu L.; Wu H.; Huang F.; Wang C.; Lan Y.; Zheng F.; Xing F.; Zhou Q.; Li Q.; Shi H.; Zhang B.; Wang Z.; Wu X.; Modafinil protects hippocampal neurons by suppressing excessive autophagy and apoptosis in mice with sleep deprivation. Br J Pharmacol 2019,176(9),1282-1297","journal-title":"Br J Pharmacol"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/biom10010137","volume":"10","author":"Cianciulli A.","year":"2020","unstructured":"Cianciulli A.; Porro C.; Calvello R.; Trotta T.; Lofrumento D.D.; Panaro M.A.; Microglia mediated neuroinflammation: Focus on PI3K modulation. Biomolecules 2020,10(1),137","journal-title":"Biomolecules"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.neulet.2014.02.039","volume":"573","author":"Walker C.L.","year":"2014","unstructured":"Walker C.L.; Xu X-M.; PTEN inhibitor bisperoxovanadium protects oligodendrocytes and myelin and prevents neuronal atrophy in adult rats following cervical hemicontusive spinal cord injury. Neurosci Lett 2014,573,64-68","journal-title":"Neurosci Lett"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1074\/jbc.M110.139410","volume":"286","author":"Guti&#xE9;rrez-Mart&#xED;n Y.","year":"2011","unstructured":"Guti&#xE9;rrez-Mart&#xED;n Y.; Bustillo D.; G&#xF3;mez-Villafuertes R.; S&#xE1;nchez-Nogueiro J.; Torregrosa-Hetland C.; Binz T.; Guti&#xE9;rrez L.M.; Miras-Portugal M.T.; Artalejo A.R.; P2X7 receptors trigger ATP exocytosis and modify secretory vesicle dynamics in neuroblastoma cells. J Biol Chem 2011,286(13),11370-11381","journal-title":"J Biol Chem"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.1111\/j.1742-4658.2009.07228.x","volume":"276","author":"G&#xF3;mez-Villafuertes R.","year":"2009","unstructured":"G&#xF3;mez-Villafuertes R.; del Puerto A.; D&#xED;az-Hern&#xE1;ndez M.; Bustillo D.; D&#xED;az-Hern&#xE1;ndez J.I.; Huerta P.G.; Artalejo A.R.; Garrido J.J.; Miras-Portugal M.T.; Ca2+\/calmodulin-dependent kinase II signalling cascade mediates P2X7 receptor-dependent inhibition of neuritogen-esis in neuroblastoma cells. FEBS J 2009,276(18),5307-5325","journal-title":"FEBS J"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cellsig.2009.01.036","volume":"21","author":"Wu P-Y.","year":"2009","unstructured":"Wu P-Y.; Lin Y-C.; Chang C-L.; Lu H-T.; Chin C-H.; Hsu T-T.; Chu D.; Sun S.H.; Functional decreases in P2X7 receptors are associ-ated with retinoic acid-induced neuronal differentiation of Neuro-2a neuroblastoma cells. Cell Signal 2009,21(6),881-891","journal-title":"Cell Signal"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"5240","DOI":"10.1038\/onc.2014.444","volume":"34","author":"Amoroso F.","year":"2015","unstructured":"Amoroso F.; Capece M.; Rotondo A.; Cangelosi D.; Ferracin M.; Franceschini A.; Raffaghello L.; Pistoia V.; Varesio L.; Adinolfi E.; The P2X7 receptor is a key modulator of the PI3K\/GSK3&#x3B2;\/VEGF signaling network: evidence in experimental neuroblastoma. Oncogene 2015,34(41),5240-5251","journal-title":"Oncogene"},{"key":"ref=185","first-page":"7443","volume":"15","author":"Yu S.","year":"2018","unstructured":"Yu S.; Hei Y.; Liu W.; Upregulation of seladin-1 and nestin expression in bone marrow mesenchymal stem cell transplantation via the ERK1\/2 and PI3K\/Akt signaling pathways in an Alzheimer\u2019s disease model. Oncol Lett 2018,15(5),7443-7449","journal-title":"Oncol Lett"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2147\/DDDT.S156920","volume":"12","author":"Hu M.","year":"2018","unstructured":"Hu M.; Li F.; Wang W.; Vitexin protects dopaminergic neurons in MPTP-induced Parkinson\u2019s disease through PI3K\/Akt signaling path-way. Drug Des Devel Ther 2018,12,565-573","journal-title":"Drug Des Devel Ther"},{"key":"ref=187","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11010-009-0312-1","volume":"337","author":"Gorbenko O.","year":"2010","unstructured":"Gorbenko O.; Panayotou G.; Volkova D.; Zhyvoloup O.; Kukharenko O.; Gout I.; Filonenko V.; Identification of novel PTEN-binding partners: PTEN interaction with fatty acid binding protein FABP4. Mol Cell Biochem 2010,337(1-2),299-305","journal-title":"Mol Cell Biochem"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12943-017-0670-3","volume":"16","author":"Zhao H.F.","year":"2017","unstructured":"Zhao H.F.; Wang J.; Shao W.; Wu C.P.; Chen Z.P.; To S-T.; Li W.P.; Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development. Mol Cancer 2017,16(1),100","journal-title":"Mol Cancer"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/82_2010_82","author":"Waite K.","year":"2010","unstructured":"Waite K.; Eickholt B.J.;  The neurodevelopmental implications of PI3K signaling Phosphoinositide 3-kinase in Health and Disease 2010,245-265","journal-title":"The neurodevelopmental implications of PI3K signaling Phosphoinositide 3-kinase in Health and Disease"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"6076","DOI":"10.1007\/s12035-017-0798-6","volume":"55","author":"Ali T.","year":"2018","unstructured":"Ali T.; Kim T.; Rehman S.U.; Khan M.S.; Amin F.U.; Khan M.; Ikram M.; Kim M.O.; Natural dietary supplementation of anthocya-nins via PI3K\/Akt\/Nrf2\/HO-1 pathways mitigate oxidative stress, neurodegeneration, and memory impairment in a mouse model of Alz-heimer\u2019s disease. Mol Neurobiol 2018,55(7),6076-6093","journal-title":"Mol Neurobiol"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.bbrc.2010.04.083","volume":"396","author":"Chen Y.L.","year":"2010","unstructured":"Chen Y.L.; Monteith N.; Law P-Y.; Loh H.H.; Dynamic association of p300 with the promoter of the G protein-coupled rat delta opioid receptor gene during NGF-induced neuronal differentiation. Biochem Biophys Res Commun 2010,396(2),294-298","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nm.4062","volume":"22","author":"Shojaee S.","year":"2016","unstructured":"Shojaee S.; Chan L.N.; Buchner M.; Cazzaniga V.; Cosgun K.N.; Geng H.; Qiu Y.H.; von Minden M.D.; Ernst T.; Hochhaus A.; Cazzaniga G.; Melnick A.; Kornblau S.M.; Graeber T.G.; Wu H.; Jumaa H.; M&#xFC;schen M.; PTEN opposes negative selection and ena-bles oncogenic transformation of pre-B cells. Nat Med 2016,22(4),379-387","journal-title":"Nat Med"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.expneurol.2016.03.008","volume":"283","author":"Gaesser J.M.","year":"2016","unstructured":"Gaesser J.M.; Fyffe-Maricich S.L.; Intracellular signaling pathway\nregulation of myelination and remyelination in the CNS. Exp Neurol 2016,283(Pt B),501-511","journal-title":"Exp Neurol"},{"key":"ref=194","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ajmg.c.31401","author":"Mirzaa G.M.","year":"2014","unstructured":"Mirzaa G.M.;  Poduri, A Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology, American Journal of Medical Genetics Part C: Seminars in Medical Genetics 2014,156-172","journal-title":"Poduri, A Megalencephaly and hemimegalencephaly: breakthroughs in molecular etiology, American Journal of Medical Genetics Part C: Seminars in Medical Genetics"},{"key":"ref=195","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.bbrc.2008.01.164","volume":"368","author":"Chen Y.L.","year":"2008","unstructured":"Chen Y.L.; Law P-Y.; Loh H.H.; NGF\/PI3K signaling-mediated epigenetic regulation of delta opioid receptor gene expression. Biochem Biophys Res Commun 2008,368(3),755-760","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=196","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.pbb.2010.02.007","volume":"95","author":"Guan X-H.","year":"2010","unstructured":"Guan X-H.; Lu X-F.; Zhang H-X.; Wu J-R.; Yuan Y.; Bao Q.; Ling D-Y.; Cao J-L.; Phosphatidylinositol 3-kinase mediates pain be-haviors induced by activation of peripheral ephrinBs\/EphBs signaling in mice. Pharmacol Biochem Behav 2010,95(3),315-324","journal-title":"Pharmacol Biochem Behav"},{"key":"ref=197","doi-asserted-by":"publisher","first-page":"e13167","DOI":"10.1111\/apha.13167","volume":"225","author":"Zhang T.","year":"2019","unstructured":"Zhang T.; Shi Z.; Wang Y.; Wang L.; Zhang B.; Chen G.; Wan Q.; Chen L.; Akt3 deletion in mice impairs spatial cognition and hippo-campal CA1 long long-term potentiation through downregulation of mTOR. Acta Physiol (Oxf) 2019,225(1),e13167","journal-title":"Acta Physiol (Oxf)"},{"key":"ref=198","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12974-016-0660-1","volume":"13","author":"Wang P.","year":"2016","unstructured":"Wang P.; He Y.; Li D.; Han R.; Liu G.; Kong D.; Hao J.; Class I.; Class I PI3K inhibitor ZSTK474 mediates a shift in microgli-al\/macrophage phenotype and inhibits inflammatory response in mice with cerebral ischemia\/reperfusion injury. J Neuroinflammation 2016,13(1),192","journal-title":"J Neuroinflammation"},{"key":"ref=199","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/mp.2013.192","volume":"20","author":"Leng Y.","year":"2015","unstructured":"Leng Y.; Wang Z.; Tsai L-K.; Leeds P.; Fessler E.B.; Wang J.; Chuang D-M.; FGF-21, a novel metabolic regulator, has a robust neuro-protective role and is markedly elevated in neurons by mood stabilizers. Mol Psychiatry 2015,20(2),215-223","journal-title":"Mol Psychiatry"}],"container-title":["Current Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X20666220119125040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200372\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1570159X20666220119125040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T11:24:15Z","timestamp":1747308255000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200372\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":199,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1570159x20666220119125040","relation":{},"ISSN":["1570-159X"],"issn-type":[{"value":"1570-159X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-07-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}